You can use your existing Medical Independent, MediLearning or PharmacistCPD account to log in. is Ireland's only investigative medical news website for doctors, healthcare professionals and anyone with an interest in health issues.

Established in 2010, along with its sister publication The Medical Independent, our stated aim is to investigate and analyse the major issues affecting healthcare and the medical profession in Ireland. The Medical Independent has won a number of awards for its investigative journalism, and its stories are frequently picked up by national digital, broadcast and print media. The Medical Independent is published by GreenCross Publishing.

Address: Top Floor, 111 Rathmines Road Lr, Dublin 6

Tel: 353 (01) 441 0024

GreenCross Publishing is owned by Graham Cooke.

The benefits of registering: only registered users:
  • receive the ecCopy two days prior to the printed edition.
  • have automatic access to our free CPD sites.
  • can partake in our online MCQs.
  • can enter our online sports quiz.

Sign up now for ease of access to The Medical Independent, Ireland’s most frequently published medical newspaper, delivering award-winning news and investigative reporting.

Download the new Mindo app for both IOS & Android.

  • Get notified when a story goes live
  • Access Premium Content
  • Read Offline
[the_ad_placement id="main-ldb-public"]
[the_ad_placement id="main-ldb-mobile-public"]

You are reading 1 of 2 free-access articles allowed for 30 days

Steady increase in patients receiving Suboxone

By Dermot - 09th Mar 2020 | 5 views

There was a steady increase in the number of patients attending for opioid substitution treatment (OST) with buprenorphine/naloxone (Suboxone) in the final months of last year, according to recent figures provided to this newspaper.

New HSE figures show this number had increased to 261 by December. This compares with 203 patients, as reported in the Medical Independent (MI) in April 2019.

At the end of 2017, there were 110 patients in receipt of Suboxone, an alternative substitution treatment for opioid drug dependence. New regulations were introduced in November 2017 to provide access to certain buprenorphine-based medicinal products in the OST system on the same statutory basis as methadone. HSE figures showed that, in September, 237 patients were receiving Suboxone, 240 in October, 249 in November and 261 in December. GPs contacted by MI last August said access to Suboxone was working well but they did not predict a major shift of patients from methadone.

In December, there were 9,713 patients attending for methadone treatment, according to the HSE.

“It is the HSE’s intention to expand the availability of opioid substitution treatment (buprenorphine-based products) as appropriate,” a HSE spokesperson told MI.

“Training has been delivered in HSE addiction services in relation to buprenorphine/naloxone (Suboxone) prescribing.

“Level II GPs in the community who have received training can also prescribe.

“We continue to monitor the numbers in receipt of this form of OST and encourage services to consider this option when appropriate when treating individuals with opioid dependence syndrome.”

Leave a Reply

[the_ad_placement id="main-ldb-public-2"]
[the_ad_placement id="main-ldb-mobile-public-2"]
Latest Issue
The Medical Independent – 24 June 2021

You need to be logged in to access this content. Please login or sign up using the links below.

[the_ad_placement id="main-mpu-public"]
Most Read
[the_ad_placement id="main-ldb-public-2"]
[the_ad_placement id="main-ldb-mobile-public-2"]